Literature DB >> 7247352

Sensitive radioimmunoassay for vancomycin.

K L Fong, D H Ho, L Bogerd, T Pan, N S Brown, L Gentry, G P Bodey.   

Abstract

A radioimmunoassay for vancomycin has been developed which uses rabbit antiserum induced by vancomycin-bovine serum albumin conjugates and vancomycin labeled with 3H or 125I. Using either isotope, the method is simple and reproducible and has a sensitivity of 4 or 0.04 ng/ml, depending on the tracer used. This is 200- to 20,000-fold improvement in sensitivity compared with the most sensitive bioassay. Drug levels in serum or urine samples from patients receiving vancomycin can be determined by this assay procedure without processing. The data obtained with 3H and 125I labels were in good agreement. Patients' plasma vancomycin concentrations determined by radioimmunoassay correlated well with those determined by bioassay when the drug was administered intravenously. However, after oral administration the drug could be detected only by radioimmunoassay. The antiserum was evaluated for cross-reactivity with a wide variety of antibiotics and cancer chemotherapeutic agents, and no significant interference was found.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7247352      PMCID: PMC181372          DOI: 10.1128/AAC.19.1.139

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Vancomycin concentration in human tissues--preliminary report.

Authors:  J R Torres; C V Sanders; A C Lewis
Journal:  J Antimicrob Chemother       Date:  1979-07       Impact factor: 5.790

2.  Effect of prophylactic measures on the microbial flora of patients in protected environment units.

Authors:  G P Bodey; B Rosenbaum
Journal:  Medicine (Baltimore)       Date:  1974-05       Impact factor: 1.889

3.  Sensitive bioassay for vancomycin.

Authors:  C A Walker; B Kopp
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

4.  Structural studies on the antibiotic vancomycin; the nature of the aromatic rings.

Authors:  K A Smith; D H Williams; G A Smith
Journal:  J Chem Soc Perkin 1       Date:  1974

5.  The structure of an amino-sugar from the antibiotic vancomycin.

Authors:  W D Weringa; D H Williams; J Feeney; J P Brown; R W King
Journal:  J Chem Soc Perkin 1       Date:  1972

6.  Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrations.

Authors:  K B Crossley; J C Rotschafer; M M Chern; K E Mead; D E Zaske
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

7.  Structure of vancomycin and its complex with acetyl-D-alanyl-D-alanine.

Authors:  G M Sheldrick; P G Jones; O Kennard; D H Williams; G A Smith
Journal:  Nature       Date:  1978-01-19       Impact factor: 49.962

Review 8.  Vancomycin revisited.

Authors:  F V Cook; W E Farrar
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

9.  High performance liquid chromatographic assay of vancomycin in serum.

Authors:  J R Uhl; J P Anhalt
Journal:  Ther Drug Monit       Date:  1979       Impact factor: 3.681

View more
  12 in total

1.  Determination of vancomycin in human serum by high-pressure liquid chromatography.

Authors:  F Jehl; C Gallion; R C Thierry; H Monteil
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

2.  Comparison of radioimmunoassay and fluorescent polarization immunoassay for quantitative determination of vancomycin concentrations in serum.

Authors:  B H Ackerman; H G Berg; R G Strate; J C Rotschafer
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

3.  Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay.

Authors:  M A Pfaller; D J Krogstad; G G Granich; P R Murray
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

4.  Evaluation of an automated fluorescence polarization immunoassay for vancomycin.

Authors:  B H Filburn; V H Shull; Y M Tempera; J D Dick
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

5.  Comparison of fluorescence polarization immunoassay and bioassay of vancomycin.

Authors:  D J Pohlod; L D Saravolatz; M M Somerville
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

Review 6.  Clinical pharmacokinetics of vancomycin.

Authors:  G R Matzke; G G Zhanel; D R Guay
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

7.  Effects of hepatic function on vancomycin clinical pharmacology.

Authors:  N Brown; D H Ho; K L Fong; L Bogerd; A Maksymiuk; R Bolivar; V Fainstein; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

8.  Comparison of vancomycin disposition in rats with normal and abnormal renal functions.

Authors:  M S Engineer; D H Ho; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

Review 9.  Serum level monitoring of antibacterial drugs. A review.

Authors:  M Wenk; S Vozeh; F Follath
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

10.  Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics.

Authors:  Andres F Zuluaga; Maria Agudelo; Carlos A Rodriguez; Omar Vesga
Journal:  BMC Clin Pharmacol       Date:  2009-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.